Churchill Capital Corp XII

Churchill Capital Corp XII(CXII)股票分析

$10.399

+0.064 (+0.62%)收盤時

Loading chart…
最高
10.400
開盤
10.400
成交量加權均價
10.40
成交量
1.93K
市值
—
最低
10.399
成交金額
20.04K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Churchill Capital Corp XII is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has conducted no operations and has generated no revenue.

AI 分析 of Churchill Capital Corp XII (CXII)

持有

Churchill Capital Corp XII (CXII) is currently trading at $10.34, which is close to its 200-day simple moving average of $10.64, indicating a potential support level. The RSI is at 32.11, suggesting that the stock is oversold, which could indicate a buying opportunity, but caution is warranted due to its high P/E ratio of 258.99 and negative earnings in Q1 2026. The stock has shown a 5-day change of -0.14% and a 20-day change of -4.22%, reflecting a downward trend. The main risk is the current ratio of 12.07 in Q2, which, while indicating good liquidity, follows a very low ratio of 0.04 in Q1, suggesting volatility in financial health.

估值指標

Churchill Capital Corp XII(CXII)目前預期本益比為 0.00,5 年平均預期本益比為 。

預期本益比

5 年均值 P/E
目前P/E
0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA
目前EV/EBITDA
0.00

預期股價營收比

5 年均值 P/S
目前P/S
0.00

持有 CXII 的大戶

M

Magnetar Capital Partners, LP

+ 持有CXII

+3.27%

3個月報酬率

S

Sculptor Capital Management, Inc.

+ 持有CXII

-4.64%

3個月報酬率

CXII 常見問題 —— 由 Alphio AI 解答

Churchill Capital Corp XII is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has conducted no operations and has generated no revenue. It operates in the Financials sector.

Churchill Capital Corp XII (CXII) is currently trading at $10.34, which is close to its 200-day simple moving average of $10.64, indicating a potential support level. The RSI is at 32.11, suggesting that the stock is oversold, which could indicate a buying opportunity, but caution is warranted due to its high P/E ratio of 258.99 and negative earnings in Q1 2026. The stock has shown a 5-day change of -0.14% and a 20-day change of -4.22%, reflecting a downward trend. The main risk is the current ratio of 12.07 in Q2, which, while indicating good liquidity, follows a very low ratio of 0.04 in Q1, suggesting volatility in financial health.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易